Evaluation of an amsacrine analog in a human tumor cloning system
- PMID: 2752503
- DOI: 10.1007/BF00257623
Evaluation of an amsacrine analog in a human tumor cloning system
Abstract
A human tumor-cloning system was used to compare the antitumor activity of CI-921, a new amsacrine analog with that of its parent compound (amsacrine gluconate). A total of 48 specimens of 9 histologically different types of human malignancy were evaluable for a direct comparison of the cytotoxic activity. Both compounds were tested simultaneously at 10 micrograms/ml final concentration under continuous exposure. The overall activity was similar for both drugs, but the degree of cross-resistance was low. We concluded that in patients, CI-921 might have a different spectrum of antitumor activity from that of its parent compound.
Similar articles
-
Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.Cancer Chemother Pharmacol. 1994;34(2):159-65. doi: 10.1007/BF00685934. Cancer Chemother Pharmacol. 1994. PMID: 8194167
-
Cytokinetic resistance of Lewis lung carcinoma to cyclophosphamide and the amsacrine derivative CI-921.Prog Clin Biol Res. 1986;223:47-61. Prog Clin Biol Res. 1986. PMID: 3809201 No abstract available.
-
Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.J Med Chem. 1987 Apr;30(4):652-8. doi: 10.1021/jm00387a012. J Med Chem. 1987. PMID: 3560159
-
[Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus].Bull Cancer. 1997 Oct;84(10):941-8. Bull Cancer. 1997. PMID: 9435795 Review. French.
-
The possible role of electron-transfer complexes in the antitumour action of amsacrine analogues.Biophys Chem. 1990 Apr;35(2-3):203-12. doi: 10.1016/0301-4622(90)80009-v. Biophys Chem. 1990. PMID: 2204443 Review.